256-slice CT images body and heart
Coronal views (top) obtained with an experimental 256-slice CT scanner show hypervascular hepatocellular carcinoma and an artery feeding the cancer. The arterial phase is shown in maximum intensity projections 30 to 38 seconds after intracoronary injection of contrast media. The scanner, a collaborative effort between Toshiba and the National Institute of Radiological Sciences in Chiba, Japan, has been used to construct a volume-rendered image of normal heart enhanced by intravenous injection of contrast agent (middle). The left anterior descending artery (arrow) and diagonal branches (stars) are visualized on the left ventricle (bottom left). A volume-rendered image of a normal heart, obtained with the 256-slice CT, shows the circumflex artery (arrow, bottom right). Prototype conebeam CT captures the entire heart in a single gantry rotation. (Provided by National Institute of Radiological Sciences)
Coronal views (top) obtained with an experimental 256-slice CT scanner show hypervascular hepatocellular carcinoma and an artery feeding the cancer. The arterial phase is shown in maximum intensity projections 30 to 38 seconds after intracoronary injection of contrast media. The scanner, a collaborative effort between Toshiba and the National Institute of Radiological Sciences in Chiba, Japan, has been used to construct a volume-rendered image of normal heart enhanced by intravenous injection of contrast agent (middle). The left anterior descending artery (arrow) and diagonal branches (stars) are visualized on the left ventricle (bottom left). A volume-rendered image of a normal heart, obtained with the 256-slice CT, shows the circumflex artery (arrow, bottom right). Prototype conebeam CT captures the entire heart in a single gantry rotation. (Provided by National Institute of Radiological Sciences)
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
